Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATM is a protein involved in neurodegeneration research. Key relationships include: interacts with, associated with, activates. Associated with AD, ALI, ALS. Connected to 589 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ATM |
| Full Name | Ataxia-Telangiectasia Mutated |
| Chromosome | 11q22.3 |
| Protein Type | Serine/Threonine Kinase |
| Function | is a PIKK-family serine/threonine kinase that coordinates genomic stress responses, especially after DNA double-strand breaks. |
| Pathways | Akt, Apoptosis, Autophagy, Cell Cycle, Dna Damage Response |
| UniProt ID | [Q13315](https://www.uniprot.org/uniprotkb/Q13315) |
| Ensembl ID | ENSG00000149311 |
| GeneCards | ATM |
| Human Protein Atlas | ATM |
| Associated Diseases | AD, Aging, ALI, Als, Alzheimer |
| Known Drugs/Compounds | mtDNA, rapamycin |
| Interactions | ABCD3, ACETYL-COA, Actin, AGING, AKT, ALOX |
| KG Connections | 1359 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ATM["ATM"] -->|"expressed in"| synaptic_vesicles["synaptic vesicles"]
ATM["ATM"] -->|"expressed in"| endosomes["endosomes"]
ATM["ATM"] -->|"expressed in"| lysosomes["lysosomes"]
ATM["ATM"] -->|"interacts"| ATR["ATR"]
ATM["ATM"] -->|"interacts"| Dementia["Dementia"]
ATM["ATM"] -->|"interacts"| Cardiovascular["Cardiovascular"]
CAT["CAT"] -->|"interacts"| ATM["ATM"]
OPTN["OPTN"] -->|"interacts"| ATM["ATM"]
DNM1L["DNM1L"] -->|"interacts"| ATM["ATM"]
CANX["CANX"] -->|"interacts"| ATM["ATM"]
style ATM fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| ATM | encodes | protein | 0.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | associated_with | disease | 0.90 |
| Senescence | activates | disease | 0.85 |
| RFWD3 | phosphorylates | gene | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| Als | activates | disease | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Ataxia | activates | disease | 0.85 |
| neural stem cells | regulates | cell_type | 0.80 |
| neural stem cells | activates | cell_type | 0.80 |
| autophagy pathway | participates_in | pathway | 0.80 |
| Ferroptosis | associated_with | process | 0.80 |
| DLBCL | biomarker_for | disease | 0.80 |
| Als | inhibits | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| mtDNA | modulates | compound | 0.75 |
| Mitochondrial dysfunction | associated_with | phenotype | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| ATR | interacts_with | protein | 0.70 |
| epigenetic regulation | participates_in | pathway | 0.70 |
| neurons | activates | cell_type | 0.70 |
| unfolded protein response | participates_in | pathway | 0.70 |
| lysosomes | expressed_in | cell_type | 0.70 |
| endosomes | expressed_in | cell_type | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| synaptic vesicles | expressed_in | cell_type | 0.70 |
| DNA | disrupts | gene | 0.70 |
| senescence | participates_in | pathway | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| CELL DEATH | regulates | phenotype | 0.70 |
| Dna Repair | activates | pathway | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| Autophagy-Lysosomal Pathway | regulates | process | 0.70 |
| CREB | treats | gene | 0.70 |
| TNF | stabilizes | gene | 0.70 |
| TNF | inhibits | gene | 0.70 |
| Mapk | activates | pathway | 0.70 |
| STING1 | regulates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| ULK1 | activates | gene | 0.70 |
| LC3 | regulates | gene | 0.70 |
| AUTOPHAGY | associated_with | phenotype | 0.70 |
| MAP1LC3B | regulates | gene | 0.70 |
| TDP-43 | regulates | gene | 0.70 |
| Dna Damage Response | associated_with | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ATM | encodes | gene | 0.00 |
| DNA | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| TP53 | inhibits | gene | 0.80 |
| P53 | activates | gene | 0.80 |
| INFLAMMATION | activates | gene | 0.80 |
| GENES | inhibits | gene | 0.70 |
| DNA | inhibits | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| ATG | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| ATG | regulates | gene | 0.70 |
| FERROPTOSIS | causes | phenotype | 0.70 |
| AUTOPHAGY | transports | phenotype | 0.65 |
| FERROPTOSIS | interacts_with | phenotype | 0.65 |
| CGAS | associated_with | gene | 0.60 |
| TFAM | associated_with | gene | 0.60 |
| ARNTL | associated_with | gene | 0.60 |
| POLG | associated_with | gene | 0.60 |
| MFN1 | interacts_with | gene | 0.60 |
| DDIT3 | interacts_with | gene | 0.60 |
| BMAL1 | associated_with | gene | 0.60 |
| STING1 | associated_with | gene | 0.60 |
| AMBRA1 | activates | entity | 0.60 |
| FANCD2 | associated_with | gene | 0.60 |
| NCOA4 | associated_with | gene | 0.60 |
| WFS1 | associated_with | gene | 0.60 |
| HARS | associated_with | gene | 0.60 |
| MRE11 | activates | gene | 0.60 |
| PTEN | regulates | gene | 0.60 |
| SMAC | activates | gene | 0.60 |
| BID | regulates | gene | 0.60 |
| ATR | regulates | gene | 0.60 |
| H2AX | therapeutic_target | gene | 0.60 |
| TBK1 | activates | gene | 0.60 |
| CDKN2A | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| AKT | contributes_to | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
| SOX2 | biomarker_for | gene | 0.60 |
| TMEM173 | associated_with | gene | 0.60 |
| MTOR | biomarker_for | gene | 0.60 |
| PTK2B | associated_with | gene | 0.60 |
| GATA2 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| ATM Kinase Hyperactivation Triggers DNA Damage Response Over | 0.837 | als | - |
| C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD | 0.720 | neurodegeneration | Test Hypothesis Fixtures |
| Multi-Biomarker Composite Index Surpassing Amyloid PET for T | 0.579 | neurodegeneration | Multi-modal Biomarker Panel Design for E |
| Dynamic Microglial Phenotype Switching Biomarker Panel for N | 0.577 | neurodegeneration | What amyloid threshold level is required |
| Optogenetic restoration of hippocampal gamma oscillations vi | 0.555 | alzheimers | Circuit-level neural dynamics in neurode |
| Combined p-tau217 + p-tau231 Panel Increases Specificity for | 0.546 | neurodegeneration | - |
| CSF p-tau217 Threshold of <0.15 pg/mL Predicts Durable Clini | 0.512 | neurodegeneration | - |
| Rational design of small molecules targeting TDP-43 liquid-t | 0.510 | neurodegeneration | Test |
| Hyaluronidase Treatment Disrupts Perivascular Inflammatory N | 0.000 | - | Microglia-astrocyte crosstalk amplificat |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567] | Guerreiro S, Privat AL, Bressac L, Toulo | Cells | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567] | Guerreiro S, Privat AL, Bressac L, Toulo | Cells | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ATM in their description or question text
Score: 0.510 · neurodegeneration · 2026-05-01
TDP-43 undergoes pathological liquid-liquid phase separation in ALS/FTD, and small molecules that restore liquid-like pr
Score: 0.000 · unknown disease · 2026-04-28
Reactive astrocytes deposit hyaluronic acid that traps inflammatory mediators in perivascular spaces, creating persisten